基础医学与临床 ›› 2015, Vol. 35 ›› Issue (1): 117-121.

• 短篇综述 • 上一篇    下一篇

NLRP3炎性小体研究进展

魏祺1,程晓曙2   

  1. 1. 南昌大学第二附属医院
    2. 南昌大学第二附属医院心内科
  • 收稿日期:2014-04-08 修回日期:2014-07-17 出版日期:2015-01-05 发布日期:2014-12-30
  • 通讯作者: 程晓曙 E-mail:xiaoshumenfan@126.com
  • 基金资助:
    国家“十二五”科技支撑计划

Research advances in NLRP3 inflammasome

  • Received:2014-04-08 Revised:2014-07-17 Online:2015-01-05 Published:2014-12-30

摘要: 炎性小体是一种多蛋白复合体,它能够识别多种病原微生物及应激相关内源性信号分子,在固有免疫中发挥重要作用。炎性小体可通过活化半胱氨酸天冬氨酸酶-1(caspase-1)诱导促炎因子IL-1β和IL-18的成熟、释放,引起炎性反应,参与多种疾病如家族性周期性自身炎性反应、缺血再灌注损伤和动脉粥样硬化等的发生发展过程。

关键词: 炎性小体, NLRP3, IL-1β

Abstract: Inflammasomes are multiprotein complexes that can recognize pathogenic microorganisms and stress-associated endogenous molecules and play an important role in innate immune system.Inflammasomes cause inflammatory response by inducing maturation of inflammatory cytokines interleukin(IL)-1β and IL-18 through activation of caspase-1,and involve in the pathogenesis of various diseases such as cryopyrin-associated periodic syndrome、ischemia-reperfusion injury and atherosclerosis.

Key words: inflammasome, NLRP3, IL-1β

中图分类号: